Precipio, Inc. (NASDAQ:PRPO – Get Rating) Director Richard A. Sandberg bought 20,000 shares of the business’s stock in a transaction that occurred on Friday, January 20th. The shares were acquired at an average cost of $0.78 per share, with a total value of $15,600.00. Following the completion of the purchase, the director now owns 40,846 shares of the company’s stock, valued at $31,859.88. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Precipio Stock Down 2.4 %
PRPO stock opened at $0.80 on Tuesday. Precipio, Inc. has a 12 month low of $0.47 and a 12 month high of $1.77. The firm has a market cap of $18.26 million, a PE ratio of -1.54 and a beta of 2.16. The firm has a 50 day simple moving average of $0.68 and a 200 day simple moving average of $0.92. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.68 and a quick ratio of 1.53.
Precipio (NASDAQ:PRPO – Get Rating) last released its earnings results on Thursday, November 10th. The biotechnology company reported ($0.14) EPS for the quarter. Precipio had a negative net margin of 128.09% and a negative return on equity of 56.55%. The business had revenue of $2.22 million for the quarter.
Institutional Trading of Precipio
Precipio Company Profile
Precipio, Incis a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.
- Get a free copy of the StockNews.com research report on Precipio (PRPO)
- Is the Northrop Grumman Selloff an Opportunity?
- Is the Worst Behind for Under Armor Stock with a New CEO?
- What Does Microsoft’s Investment in ChatGBT Mean for MSFT Stock?
- Analysts Like The Fit Of Skechers USA
- Can We Trust The Rally In The S&P 500
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.